SCHEMBL7091825

SCHEMBL7091825

CCC(CCN1CCCCCC1=O)NC(C)Cc1cccc(-c2ccccc2C(N)=O)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.42
PLA2G10 O15496 6/20 0.41
PLA2G2A P14555 6/20 0.41
PLA2G1B P04054 1/20 0.40
PLA2G5 P39877 1/20 0.40
PLA2G2C Q5R387 1/20 0.40
PLA2G12B Q9BX93 1/20 0.40
PLA2G12A Q9BZM1 1/20 0.40
PLA2G2F Q9BZM2 1/20 0.40
PLA2G3 Q9NZ20 1/20 0.40
PLA2G2E Q9NZK7 1/20 0.40
PLA2G2D Q9UNK4 1/20 0.40
PDK2 Q15119 2/20 0.38
CD274 Q9NZQ7 4/20 0.34
SOAT2 O75908 2/20 0.34
SOAT1 P35610 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
KMT2A Q03164 1/20 0.34
GRIA2 P42262 1/20 0.34
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7091821 0.80 PLA2G2A (0.41) LMNAPLA2G10PLA2G2APLA2G1BPLA2G5
SCHEMBL4874217 0.76 ACKR3 (0.42) LMNAKMT2ARAB9A
SCHEMBL4876185 0.74 ACKR3 (0.43) LMNAL3MBTL1KMT2A
SCHEMBL4873305 0.71 PARP1 (0.40) LMNASOAT2SOAT1KMT2AGRIA2
SCHEMBL4870511 0.67 SOAT2 (0.42) LMNACD274SOAT2SOAT1L3MBTL1
SCHEMBL4870307 0.66 SOAT2 (0.41) LMNACD274SOAT2SOAT1L3MBTL1
SCHEMBL21357017 0.65 BCAT2 (0.59) PLA2G10PLA2G2APLA2G1BPLA2G5PLA2G2C
SCHEMBL4871334 0.65 KMT2A (0.40) LMNASOAT2SOAT1KMT2ARAB9A
SCHEMBL4875904 0.65 SOAT2 (0.39) LMNASOAT2SOAT1L3MBTL1KMT2A
SCHEMBL4876529 0.65 KMT2A (0.39) LMNASOAT2SOAT1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1289965-A1 SUBSTITUTED 1-AMINOALKYL-LACTAMS AND THEIR USE AS MUSCARINIC RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2003-03-12 EP disclosed
WO-2001090081-A1 SUBSTITUTED 1-AMINOALKYL-LACTAMS AND THEIR USE AS MUSCARINIC RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-11-29 WO disclosed